Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first autologous ...

Disclaimer: This news article is a direct feed from ANI and has not been edited by the News Nation team. The news agency is ...